⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Official Title: FK506 Phase 3 Study: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Study ID: NCT00309101

Interventions

tacrolimus

Study Description

Brief Summary: The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.

Detailed Description:

Eligibility

Minimum Age: 16 Years

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, Chubu region, , Japan

, Chugoku region, , Japan

, Hokkaido region, , Japan

, Hokuriku region, , Japan

, Kansai region, , Japan

, Kanto region, , Japan

, Kyushu region, , Japan

, Shikoku region, , Japan

, Tohoku region, , Japan

Contact Details

Name: Central Contact

Affiliation: Astellas Pharma Inc

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: